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i. Summary/Abstract 
 Several recent studies in immunology have used multiphoton laser-scanning 
microscopy to visualise the induction of an immune response in real time in vivo. 
These experiments are illuminating the cellular and molecular interactions involved in 
the induction, maintenance and regulation of immune responses. Similar approaches 
are being applied in cardiovascular research where there is an increasing body of 
evidence to support a significant role for the adaptive immune system in vascular 
disease. As such, we have begun to dissect the role of T lymphocytes in 
atherosclerosis in real time in vivo. Here, we provide step-by-step guides to the 
various stages involved in visualising the migration of T cells within a lymph node 
and their infiltration into inflamed tissues such as atherosclerotic arteries. These 
methods provide an insight into the mechanisms involved in the activation and 
function of immune cells in vivo. 
 
ii. Key Words 
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1. Introduction 
 Atherosclerosis has been recognised as an inflammatory disease and much of the 
current research is focused on investigating how this inflammation is regulated. 
Adaptive immunity is highly involved in atherogenesis (1, 2), but we still have much 
to learn about its effective role in the pathology. The adaptive immune system is a 
complex collection of cells, that interact in distinct locations in a tightly regulated 
manner in order to allow the rapid induction of immunity and prevent the induction of 
inappropriate responses. Failure of this regulation is associated with development of 
many inflammatory and autoimmune diseases such as atherosclerosis and rheumatoid 
arthritis. Importantly, the stochastic generation of antigen receptor diversity produces 
a low frequency of antigen-specific cells. In order to provide effective immune 
surveillance, these cells must therefore migrate throughout the body in search of 
cognate antigen presented upon dendritic cells (DCs). The contact between an 
antigen-presenting cell and a naïve T cell can have important consequences for the 
induction of immunity since failure to establish stable cell-cell interactions prevents 
the optimal activation of T cell responses (3-6), which may be of benefit in 
therapeutic applications. Analysing the cellular interactions during the induction, 
maintenance and effector stages of an immune response therefore provides insight 
into how antigen-specific immunity may be manipulated for therapeutic benefit. 
Indeed, molecules involved in these interactions (such as CTLA-4, CD28 and CD3) 
have recently been targeted for therapeutic use. 
 Whilst a range of imaging techniques have been applied to immunology over 
recent years, few have provided such an insight into the cellular interactions involved 
in the induction of immune responses as multiphoton laser-scanning microscopy 
(MPLSM) (3-16). Studies using MPLSM have demonstrated that naïve T cells show 
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rapid motility within the lymph node (LN), contacting multiple DCs per hour, 
allowing them to effectively scan for antigen (7-9). Following antigen recognition, T 
cells reduce their velocity and remain associated with the antigen-presenting DC (8-
10). The dynamics and kinetics of this interaction have important implications in the 
induction of immunity, with a stable interaction being required for effective T cell 
priming, whereas shorter/less contact results in the failure of immunity and/or 
tolerance (3-6). More recently, the role of specific molecules involved in the 
activation and regulation of these DC:T cell interactions have been investigated, 
providing a mechanistic insight into immune activation (11, 17). However, in the 
majority of inflammatory-based pathogeneses, it is the somatic tissues which are the 
target of disease. Whilst many important studies have investigated the role of cells 
within the LNs or in the tissues of these diseases, few have examined the interaction 
between these sites. Thus, it is often assumed that observations made in the LN apply 
to cells in the tissue and vice-versa (e.g. in vivo observations of CTL activity, which 
may not carry out killing in the LN under normal conditions). Clearly, this may not 
actually be the case, and therefore it is important to examine the cellular behaviour of 
cells in the tissue AND in the LN and eventually to image the migration between 
them. As such, we have begun to investigate the relationships between the immune 
and cardiovascular systems by imaging the LN and artery (16) in real time in vivo. 
Lymphocytes infiltrate the arterial wall before and during development of 
atherosclerosis (16, 18), but we still need to investigate their potential antigens, their 
contact-dependent activities and cross-talk with other cells within or outside the 
atherosclerotic vessels. A major hurdle is the limited knowledge regarding secondary 
lymphoid tissue where priming of atherogenic T cells should take place, such as the 
draining LNs. Thus, imaging immune cell behaviour directly in intact atherosclerotic 
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vessels, as well as the associated lymphoid tissues (if any) could provide important 
information for the development and use of immune specific therapies in vascular 
pathology, as well as an improved understanding of the migration and interactions of 
cells involved in immune pathology. 
 Here we provide a description of how samples are prepared for imaging in order 
to analyse the behaviour of T cells in vivo not only within the lymph node but also a 
potential target tissue, the atherosclerotic blood vessel. Whilst most studies to date 
have used adoptively transferred populations of antigen-specific T cells, there is an 
increasing use of mice in which fluorescent reporters are expressed by specific 
subsets of cells or induced under certain conditions and these could be used in the 
following protocols. Unfortunately, there are currently few MPLSM systems that 
provide the tuneable excitation laser, accurate scan head and sensitive detection 
system essential for in vivo imaging. Hence, most groups use customised microscope 
systems along with environmental control systems to maintain tissue viability. The 
methods and notes described here should help in establishing imaging systems for the 
visualisation of T cell migration within the lymph node and the target tissue it drains. 
 
2. Materials 
2.1. Mice 
 A selection of mice have been used in MPLSM imaging experiments, depending 
on the exact experimental question. Commonly, T cell receptor (TCR) transgenic 
animals are used as donors for adoptive transfer, allowing the visualization of a 
population of antigen-specific T cells in the recipient animal. Typically, we have used 
the ovalbumin (OVA)-specific DO11.10 mice on a scid background. Since these mice 
are unable to generate T or B cells of any other specificity, we can be sure that all the 
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cells analyzed are the antigen-specific cells of interest. Alternatively, CD4/CD8 T cell 
isolation must be performed (19). For vascular imaging, C57BL6 or OVA-specific 
OT-II mice (on a C57BL6 background) are used as lymphocyte donors for adoptive 
transfer and Apolipoprotein E deficient mice (ApoE
-/-
, B6.129P2-ApoE
tm1Unc
), 
showing a marked increase in total plasma cholesterol levels, as recipient animals. In 
these animals, monocyte attachment to endothelial cells is observed at 6 weeks, foam 
cell lesions develop as early as 8 weeks and fatty streaks in the proximal aorta and 
carotid are found at 3 months of age. The lesions increase with age and progress to 
lesions with less lipid but more elongated cells, typical of a more advanced stage of 
pre-atherosclerotic lesion. 
 
2.2. CFSE and CMTPX stock 
5- (and-6-) carboxyfluorescein diacetate, succinimidyl ester (5(6)-CFDA, SE; 
Invitrogen, Paisley, U.K.) is prepared as a 10 mM stock solution in DMSO and kept 
frozen at -20°C in aliquots. 
Cell Tracker
TM
 Red CMTPX (Invitrogen) is prepared as a 20 mM stock solution in 
DMSO and kept frozen at -20°C in aliquots. 
 
2.3. Media 
RPMI 1640 (Sigma-Aldrich, Poole, U.K.). 
HBSS (Sigma-Aldrich). 
Complete medium [RPMI 1640, 10% Foetal calf serum (FCS), 2 mM L-glutamine, 
100 U/mL penicillin, 100 mg/mL streptomycin, 1.25 mg/mL fungizone; all obtained 
from Invitrogen]. 
CO2-independent medium (Invitrogen). 
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2.4. Other items 
Nitex membranes (Cadisch & Sons, London, U.K.) or 40 µm cell strainers (BD 
Bioscience, Oxford, U.K.). 
Plastic coverslips. 
3M™ Vetbond™ Tissue Adhesive 1469SB. 
 
3. Methods 
3.1. Removal of Lymph Nodes 
1. Cull the mouse with an increasing concentration of CO2. 
2. Spray the mouse with 70% ethanol to prevent fur from contaminating the 
region to be dissected. 
3. Lie the cadaver ventral side up, pin the mouse’s paws to the dissection board 
and place under a light source. 
4. Make an incision in the skin of the mouse from the abdomen to mandible. 
5. Make further incisions from the central one towards each paw. 
6. Separate skin from the abdominal muscles and pin out. 
7. Dissect lymph nodes (e.g. inguinal, brachial, axillary, cervical and mesenteric) 
and spleen if required (see Note 1). 
 
3.2. Preparation for adoptive transfer 
1. Harvest peripheral and mesenteric LNs from donor mice into RPMI 1640. 
2. Mash the LNs through Nitex mesh or BD cell strainers into 50 mL tube, using 
a syringe plunger. 
3. Wash fresh media through the Nitex to fill the tube. 
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4. Spin the cells at 400g for 5 minutes and resuspend the pellet in an appropriate 
volume of HBSS for counting cells (see Note 2). 
5. Count the cells using Trypan blue and a haemocytometer. 
6. Spin the cells again and resuspend at a concentration of 10
7
 lymphocytes per 
mL in appropriate pre-warmed buffer containing dyes. 
a. If labelling cells with CFSE, resuspend in HBSS 
b. If labelling with CMTPX, resuspend in CO2-independent media 
c. Add 0.5 µL of stock CFSE/CMTPX per mL of buffer (see Note 3) 
7. Immediately transfer cells to 37°C water bath and incubate with occasional 
agitation to prevent cell aggregation. 
a. For CFSE (0.5 µL stock solution/1 x 10
7
 cells/mL) labelling, incubate 
for 10--15 minutes at 37°C (loose lid) 
b. For CMTPX (0.5 µL stock solution/1 x 10
7
 cells/mL) labelling, 
incubate for 45 minutes at 37°C (loose lid) 
8. Wash cells by topping up tube with FCS-containing buffer and centrifuging at 
400g for 5 minutes (see Note 4). 
9. Resuspend pellet in RPMI 1640 and count cells using Trypan blue. 
10. Spin cells and resuspend at appropriate cell concentration for adoptive transfer 
(see Note 5). 
11. Transfer into congenic recipient mice by intravenous injection. 
 
3.3. Preparation of LN for imaging 
A step by step visual guide to LN imaging is shown in Figure 1 (15). 
1. Collect the appropriate LN for imaging and place in CO2-independent medium 
warmed to room temperature (see Notes 6-8). 
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2. When ready for imaging prepare the LN by rolling on paper towel (Fig. 1C). 
This dries the LN a little and also allows removal of any fat still attached to 
the LN. 
3. Place a small drop of Vetbond glue onto the unbreakable plastic coverslip 
(Fig. 1D) and spread using the corner of tissue paper to give a very thin layer 
over the coverslip (Fig. 1E). 
4. Add the LN onto the coverslip directly without rolling over the glue-covered 
surface. Press down gently on the LN with forceps to secure it onto the 
coverslip but avoid putting too much force on it and damaging the capsule 
(Fig. 1F) (see Note 9). 
5. Cure the Vetbond by immersing in the CO2-independent medium (Fig. 1G). 
The plastic coverslip can now be cut down to size in order to fit into the 
imaging chamber (Fig. 1H). 
6. Apply a small amount of grease to the underside of the coverslip (Fig. 1I) to 
adhere it into the imaging chamber. 
 
3.4. Preparation of Brachiocephalic Artery for Imaging 
1. Cull and prepare the mouse as described above (section 3.1, point 1-3). 
2. Make an incision in the skin of the mouse from the abdomen to the top of the 
thorax. 
3. Open the abdominal wall below the ribcage. 
4. Lift the sternum with tweezers and cut the diaphragm. Then cut away the 
lower part of the ribcage to partially expose the heart 
5. Draw blood from the heart by sticking the needle of a 1 mL syringe into the 
apex of the left ventricle (see Note 10). 
 10 
6. Make a small incision in the right atrium for drainage. 
7. Stick a 10 mL syringe into the apex of the left ventricle and slowly flush the 
blood from the mouse with 10 mL of PBS. 
8. Dry the mouse by turning it over and pressing it against paper towels; return to 
the ventral position and re-pin the appendages. 
9. Place the mouse under a dissecting microscope. 
10. Remove the remaining ventral part of the ribcage, carefully cut the right 
clavicle leaving the brachiocephalic artery and its branches intact (Fig. 2A). 
Using microdissection scissors, remove all of the fat from around the 
ascending aorta and brachiocephalic artery. 
11. Remove the fat and tissue surrounding the heart. 
12. Cut the brachiocephalic artery distal to where it branches into the right 
subclavian and right carotid and then cut it at its branching site from the aorta 
to disclose a Y--shaped specimen (Fig. 2B); place in PBS to clean (see Note 
11). 
13. Take the cleaned piece of the brachiocephalic artery and place in CO2-
independent media warmed to room temperature. 
14. When ready for imaging place a small drop of Vetbond glue onto the 
unbreakable plastic coverslip and spread using the corner of tissue paper to 
give a very thin layer over the coverslip (Fig. 1D,E). 
15. Glue down the tail of the Y--shaped specimen of brachiocephalic artery onto 
the coverslip first, and gently lower the artery down from the opposite limb to 
secure it to the slide. Proceed as described above (section 3.3, point 5-6). 
 
3.5. Perfusion system 
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 The tissue ready for imaging is placed in a custom-built perfusion system to bathe 
tissue in warmed, oxygenated medium. Unfortunately, no off-the-shelf product is 
currently suitable for this. However, individual components are relatively easy to 
combine into a system that allows control over the flow-rate, temperature and 
oxygenation of medium throughout the imaging period (20). 
1. RPMI 1640 is pre-warmed in a microwave to around 60°C and added to the 
reservoir, where it is kept warm (see Note 12). 
2. A mixture of 95% O2, 5% CO2 is bubbled through the warmed media at a 
slow, steady rate. 
3. Medium is pumped into the imaging chamber (1.5 mL volume) at a flow rate 
of 1--2 mL per minute, ensuring adequate perfusion of medium/oxygen and 
removal of waste. 
4. Set the inline heater to warm the media above 37°C and monitor the 
temperature in the imaging chamber. Adjust until the temperature is between 
35°C and 36°C. 
 
3.6. Microscopy 
 Again, few complete MPLSM systems are commercially available ready for use 
and many groups have customized existing systems for their own use. Of the reported 
setups used, several groups (3, 4, 7, 9, 10, 20) describe systems similar to ours, 
consisting of the following: 
1. Solid-state, tunable titanium:sapphire laser system (Chameleon, Coherent Inc., 
Glasgow, U.K.). 
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2. The laser beam is routed into a multiphoton excitation laser scanning system 
(Radiance 2000MP, Bio-Rad Laboratories) through an upright microscope 
(E600-FN, Nikon). 
3. The objective lens used for all imaging investigations is a CFi-60 Nikon Fluor 
40X/0.8 NA water-dipping objective lens. 
4. The sample is illuminated with 770-830 nm light, with ~210 fs pulse duration 
and 76 MHz repetition frequency (see Note 13). 
5. Excited fluorescence passes through a laser blocking filter (E625SP, Chroma 
Technologies, Rockingham, VT) and detected with a multi-alkali cathode 
photo-multiplier tube (S20 PMT) in an external or nondescanned 
configuration as part of the Radiance 2000MP system. 
6. A filter block can be used to separate fluorescence at 500-550nm (green dyes 
or autoflorescence) from higher emitted wavelengths (red labelled cells). 
7. The scans are acquired with 500 lines per second and between 256 x 256 to 
1024 x 1024 pixel boxes, for a frame rate of 1.95 fps (see Notes 14-16). 
 
3.7. Analysis 
 Several image analysis software packages have been used in the analysis of 
MPLSM data including Imaris (Bitplane, Zurich, Switzerland), MetaMorph 
(Molecular Devices, Downingtown, PA), VideoSavant (IO Industries, Ontario, 
Canada), Picviewer (John Dempster, University of Strathclyde, Glasgow, U.K.), 
Adobe AfterEffects (San Jose, CA), ImageJ (NIH, Bethesda, MD) and Volocity 
(Improvision, Coventry, U.K.). Although many of these tools perform several similar 
analyses, Volocity software allows the visualization and rendering of images as well 
as the semi-automated quantitation of cell movement and behaviour within the 3D 
 13 
images (Fig. 3). Whilst the exact measurements required depend on the data being 
analyzed, there are certain steps that are commonly used: 
1. Objects (cells) are identified based on their fluorescence, identifying the 
centroid location of all the individual cells in the sample. 
2. Objects are linked over time by tracking an object over at least 8 time points. 
3. Many data sets can be generated simply by tracking--e.g. track velocity, 
displacement, meandering index, motility co-efficient. 
4. It is also possible to measure the interaction between DC and T cell using the 
colocalization tool to identify green and red voxels. This represents the 
amount of interaction between cells in sample and varies in different 
conditions. 
5. Results can be displayed in a variety of formats, including showing all tracks 
in an x, y, z plot, plotting the speed of individual cells or calculating the 
amount of interaction across the sample (Fig. 3). 
 
4. Notes 
1. The inguinal lymph node is typically found in the skin flap just above the leg 
and you can find it by looking at junction of blood vessels that run above it. 
Axillary lymph nodes are located right along a major blood vessel and 
sometimes dissection can be tricky because of bleeding. Superficial cervical 
LN along the side of the jaw muscles of the mouse should not be confused 
with salivary glands. Take care when isolating the mesenteric LN, since this is 
often associated with a lot of fatty tissue, which is not required. 
2. If using large numbers of donors, it is often worth centrifuging the supernatant 
from the first wash as this can increase cell yield. 
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3. It is best to add the fluorescent dye to the appropriate buffer and vortex prior 
to using to resuspend the cells. There is occasionally precipitation of CMTPX 
in CO2-independent medium and can require thorough vortexing to prevent 
clumping when added to cells. 
4. The inclusion of FCS in the wash buffer is important to remove any remaining 
free fluorescent dye. 
5. Typically transfer 2--5 x 10
6
 antigen-specific cells in a volume of 0.2 mL per 
recipient. 
6. Care is required to avoid damaging the capsule of the LN to preserve 
structure. However, it is important to avoid collecting associated fat which can 
decrease the quality of images obtained. A good way to tell if fat is removed is 
to place the LN in medium; if there is any fat it will float. 
7. Generally use the LN draining the site of antigen challenge (e.g. when 
immunizing subcutaneously in the footpad, image the popliteal LN). 
8. Medium should be warmed to room temperature in advance. Lymph nodes can 
be harvested from several mice and maintained in CO2-independent medium 
for several hours. Keep tissues at room temperature and avoid placing on ice. 
9. Normally place the LN onto the slide in a transverse orientation (i.e. on its 
side, with an apparent ‘kidney’ shape) 
10. Draw blood by slowly pulling the plunger, twisting the needle. Do not draw 
for longer than a minute as blood will start to clot. 
11. When handling the brachiocephalic artery, it is important to touch only at its 
ends and not in the middle to avoid damaging the adventitial layer. 
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12. Heating the medium as gas is bubbled through it helps prevent the build up of 
bubbles in the imaging chamber after the inline heater. These bubbles can 
often form on the tissue or objective lens, obscuring the images. 
13. Excitation wavelengths from the Ti:sapphire laser are in the range 770--
830nm, depending on fluorochrome. For single colour (CFSE) and/or 
autofluorescence imaging, excitation around 770--780nm is used. For imaging 
both CFSE and CMTPX-labelled cells, excitation is at 830nm. Green 
autoflorescence of adventitial connective tissue and elastin fibers in the 
arterial media is always visible in the range 770--830nm. Depending on laser 
power, green autoflorescence of superficial tissue nuclei can be detected at an 
excitation of 770--780nm. 
14. When setting up LN for imaging, focus to the top of the LN and then z-step 
down through the tissue to image at a known depth. Typically this is around 
200--500 µm from the top of the LN. When setting up an artery for imaging, 
focus to the top of the adventitia (autofluorescent connective tissue) and then 
z-step down through the tissue to image at a known depth (Fig. 2 C-F). 
Lamina adventitia is a major site of arterial wall lymphocyte infiltration into 
atherosclerotic arteries; typically this is around 0--30 µm from the top of the 
vessel. Lymphocyte infiltration is randomly distributed throughout the 
arteries. 
15. Typically scan an area of 256 by 256 pixels (284 µm by 284 µm) in x and y, 
with z-depth of 35--50µm (in 2.55 µm steps) 
16. The depth of the stack imaged is determined by how fast cells are moving in 
the LN--faster cells require fast imaging in order to track in software. 
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Generally, imaging a cell once every ~30 seconds is sufficient for accurate 
tracking. 
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Figure Legends 
Figure 1 
Procedure for ex vivo imaging of LN. Isolated LNs are adhered to unbreakable plastic 
coverslips (A) using veterinary-grade superglue (B). The LN is rolled on blue roll to 
remove fat (C). A thin layer of Vetbond is spread over slide using tissue paper (D & 
E) and the LN secured on this (F). The glue is cured by immersing in media (G) 
before trimming the slide to size (H). Finally, a small amount of grease is spread on 
the underside of the coverslip to secure in the imaging chamber (I). 
Figure 2 
Dissection of the brachiocephalic artery (A) and vessel isolation for imaging (B). 
Several red labelled lymphocytes are detectable mainly in adventitia (C, D, E, ~10-
30 µm below the outer surface) and within the autofluorescent elastic fibres 
(green) in the tunica media (F, ~30-50 µm below the outer surface) as shown by 
the set of longitudinal sections of ApoE 
-/-
 mouse brachiocephalic artery. 
Figure 3 
Analysis of T cell migration and interactions in the LN. Using software, individual 
cells are identified within the 3D image and then tracked over time (A). Multiple cell 
tracks can be plotted relative to each other to effectively show migration distances or 
polarized movement (B). The velocity of each track can then be graphed to compare 
the movement of different samples (e.g. to show the difference between naïve T cells 
and those recognizing antigen (C). Alternatively, the amount of interaction between 
red T cells and green DCs can be calculated as a colocalization coefficient and 
compared between two different samples (D). 
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